LALIBERTE KEVIN (Sr. VP, Product Development) sold 43.7% of their position (3.70K shares) of DOVA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $103.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/2/2019ACC: 0001562180-19-005055
Officer· Sr. VP, Product Development
Since Jan 2019
-3.70K
Net shares
Net seller
$103.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.10K
Price / share
$28.00
Trade value
$86.80K
% of position
36.7%
9/30/2019
8.46K→5.36K
Common Stock
Direct
Shares
−596.00
Price / share
$28.00
Trade value
$16.69K
% of position
11.1%
9/30/2019
5.36K→4.76K
Total
Net shares
−3.70K
Net value
-$103.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2019 | S · Sale | −3.10K | $28.00 | $86.80K | 36.7% | 8.46K | 5.36K |
| Common Stock Direct | 9/30/2019 | S · Sale | −596.00 | $28.00 | $16.69K | 11.1% | 5.36K | 4.76K |
| Total | −3.70K | -$103.49K | ||||||
Derivative Transactions0
No derivative transactions reported